Added U.S. Based Investment Announcements from Pharmaceutical Firms
Supply Chain Matters
APRIL 23, 2025
Supply Chain Matters highlights two other recent strategic announcements from pharmaceutical and drug makers that significantly increase their U.S. In early March, Supply Chain Matters highlighted an announced $27 billion investment from Eli Lilly, billed by this producer as the largest pharmaceutical manufacturing investment in U.S.
Let's personalize your content